Faron Pharmaceuticals Oy (FARN.L)
GBp 175.0
(2.94%)
GBp 175.0
(2.94%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 6.23 Million EUR | -0.68% |
| 2022 | 6.27 Million EUR | 289.93% |
| 2021 | -3.3 Million EUR | -274.41% |
| 2020 | -883 Thousand EUR | 79.16% |
| 2019 | -4.23 Million EUR | -118.97% |
| 2018 | -1.93 Million EUR | 71.89% |
| 2017 | -6.88 Million EUR | 26.39% |
| 2016 | -9.35 Million EUR | -4.6% |
| 2015 | -8.94 Million EUR | -717.05% |
| 2014 | 1.44 Million EUR | -28.73% |
| 2013 | 2.03 Million EUR | -21.75% |
| 2012 | 2.59 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -17.6 Million EUR | -382.25% |
| 2024 Q2 | -17.6 Million EUR | 1.95% |
| 2023 Q2 | 7.16 Million EUR | 1.69% |
| 2023 Q1 | 7.04 Million EUR | 12.18% |
| 2023 Q3 | 6.07 Million EUR | -15.22% |
| 2023 Q4 | 6.23 Million EUR | 2.68% |
| 2023 FY | 6.23 Million EUR | -0.68% |
| 2022 Q1 | 2.31 Million EUR | 169.99% |
| 2022 Q3 | 6.12 Million EUR | 153.14% |
| 2022 FY | 6.27 Million EUR | 289.93% |
| 2022 Q4 | 6.27 Million EUR | 2.5% |
| 2022 Q2 | 2.42 Million EUR | 4.58% |
| 2021 Q3 | -3.49 Million EUR | -1.19% |
| 2021 Q2 | -3.44 Million EUR | 4.91% |
| 2021 Q1 | -3.62 Million EUR | -310.76% |
| 2021 FY | -3.3 Million EUR | -274.41% |
| 2021 Q4 | -3.3 Million EUR | 5.27% |
| 2020 Q3 | -1.05 Million EUR | 88.04% |
| 2020 FY | -883 Thousand EUR | 79.16% |
| 2020 Q4 | -883 Thousand EUR | 16.62% |
| 2020 Q2 | -8.85 Million EUR | 2.0% |
| 2020 Q1 | -9.03 Million EUR | -113.26% |
| 2019 Q4 | -4.23 Million EUR | 3.09% |
| 2019 FY | -4.23 Million EUR | -118.97% |
| 2019 Q1 | -529 Thousand EUR | 72.66% |
| 2019 Q2 | -529 Thousand EUR | 0.0% |
| 2019 Q3 | -4.37 Million EUR | -726.47% |
| 2018 FY | -1.93 Million EUR | 71.89% |
| 2018 Q3 | -1.93 Million EUR | 78.62% |
| 2018 Q1 | -9.05 Million EUR | -31.46% |
| 2018 Q2 | -9.05 Million EUR | 0.0% |
| 2018 Q4 | -1.93 Million EUR | 0.0% |
| 2017 Q1 | -7.83 Million EUR | 16.23% |
| 2017 Q4 | -6.88 Million EUR | 0.0% |
| 2017 Q3 | -6.88 Million EUR | -18.22% |
| 2017 Q2 | -5.82 Million EUR | 25.67% |
| 2017 FY | -6.88 Million EUR | 26.39% |
| 2016 Q3 | -9.3 Million EUR | -63.11% |
| 2016 FY | -9.35 Million EUR | -4.6% |
| 2016 Q1 | -6.71 Million EUR | 24.93% |
| 2016 Q2 | -5.7 Million EUR | 15.03% |
| 2016 Q4 | -9.35 Million EUR | -0.54% |
| 2015 Q2 | -585 Thousand EUR | 0.0% |
| 2015 Q4 | -8.94 Million EUR | 4.65% |
| 2015 Q3 | -9.37 Million EUR | -1502.91% |
| 2015 Q1 | -585 Thousand EUR | -140.37% |
| 2015 FY | -8.94 Million EUR | -717.05% |
| 2014 FY | 1.44 Million EUR | -28.73% |
| 2014 Q1 | - EUR | 0.0% |
| 2014 Q3 | 1.44 Million EUR | 0.0% |
| 2014 Q4 | 1.44 Million EUR | 0.0% |
| 2013 FY | 2.03 Million EUR | -21.75% |
| 2012 FY | 2.59 Million EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|